Intangible Assets (Details) (USD $)	12 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Finite-Lived Intangible Assets [Line Items]
Gross Amount	$ 6,505,440	$ 9,229,210
Accumulated Amortization	3,020,857	2,525,905
Net	3,484,583	6,703,305
Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Useful Life (years)	4 years
Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Useful Life (years)	15 years
Acquired Customer Base [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Amount	5,145,638	7,858,775
Accumulated Amortization	2,645,715	2,257,533
Net	2,499,923	5,601,242
Acquired Customer Base [Member] | Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Useful Life (years)	5 years	5 years
Acquired Customer Base [Member] | Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Useful Life (years)	15 years	15 years
Know How [Member]
Finite-Lived Intangible Assets [Line Items]
Useful Life (years)	15 years	15 years
Gross Amount	512,000	512,000
Accumulated Amortization	179,283	145,147
Net	332,717	366,853
Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Useful Life (years)	15 years	15 years
Gross Amount	547,802	558,435
Accumulated Amortization	75,856	63,222
Net	471,946	495,213
Biomedical Technologies [Member]
Finite-Lived Intangible Assets [Line Items]
Useful Life (years)	5 years	5 years
Gross Amount	300,000	300,000
Accumulated Amortization	120,003	60,003
Net	$ 179,997	$ 239,997